Exchange Traded Concepts’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.2K	Sell	1,895 -4,254	-69%	-$102K	﹤0.01%	1450
2025 Q4	$164K	Buy	6,149 +3,795	+161%	+$90.7K	﹤0.01%	1280
2025 Q3	$50.2K	Buy	2,354 +428	+22%	+$10.1K	﹤0.01%	1296
2025 Q2	$41.5K	Buy	1,926 +150	+8%	+$2.79K	﹤0.01%	1336
2025 Q1	$29.5K	Buy	+1,776	New	+$32.3K	﹤0.01%	1240
2023 Q1	–	Sell	-5,240	Closed	-$83.4K	–	1135
2022 Q4	$83.4K	Buy	5,240 +1,303	+33%	+$20.4K	﹤0.01%	781
2022 Q3	$64K	Buy	3,937 +1,228	+45%	+$19.9K	﹤0.01%	803
2022 Q2	$38K	Buy	2,709 +2,077	+329%	+$38.8K	﹤0.01%	944
2022 Q1	$15K	Buy	+632	New	+$15.3K	﹤0.01%	1061
2021 Q2	–	Sell	-2,133	Closed	-$55K	–	1093
2021 Q1	$55K	Sell	2,133 -11,144	-84%	-$491K	﹤0.01%	802
2020 Q4	$710K	Sell	13,277 -3,048	-19%	-$151K	0.03%	279
2020 Q3	$673K	Buy	16,325 +15,596	+2,139%	+$673K	0.04%	231
2020 Q2	$35K	Sell	729 -156	-18%	-$7.49K	0.01%	559
2020 Q1	$37K	Buy	+885	New	+$36.5K	0.02%	305